Rapid Pathogen Screening, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Rapid Pathogen Screening, Inc. makes
Rapid Pathogen Screening, Inc. manufactures lateral flow immunoassay devices for point-of-care testing, including the INFLAMMA DRY for detecting inflammatory markers and the RPS ADENO DETECTOR PLUS for adenovirus detection.
These products are classified as Class I medical devices under FDA regulations and are supported by 510(k) clearance records in the U.S. The company is based in the United States.
Catalogue
Inflamma Dry Ref K132066
Regimes: 510(k) Registry: 510(k)Rps Adeno Detector Ref K052092
Regimes: 510(k) Registry: 510(k)Rps Adeno Detector Plus Ref K110722
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Rapid Pathogen Screening, Inc. have in the registry?
The registry currently lists 3 devices for Rapid Pathogen Screening, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Rapid Pathogen Screening, Inc.'s devices?
Among its 3 most recently registered devices, Rapid Pathogen Screening, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Rapid Pathogen Screening, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Rapid Pathogen Screening, Inc.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Rapid Pathogen Screening, Inc. in the registry?
The most recently registered devices listed for Rapid Pathogen Screening, Inc. include INFLAMMA DRY, RPS ADENO DETECTOR and RPS ADENO DETECTOR PLUS.